dc.contributor.author |
Hartmann, Jörg T. |
|
dc.date.accessioned |
2014-07-03T13:46:30Z |
|
dc.date.available |
2014-07-03T13:46:30Z |
|
dc.date.issued |
2014 |
|
dc.identifier.issn |
1470-2045 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/54008 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Elsevier Science Inc |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/S1470-2045(14)70063-4 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20140610213910_00258 |
de_DE |
utue.publikation.seiten |
415-423 |
de_DE |
utue.personen.roh |
Judson, Ian |
|
utue.personen.roh |
Verweij, Jaap |
|
utue.personen.roh |
Gelderblom, Hans |
|
utue.personen.roh |
Hartmann, Jorg T. |
|
utue.personen.roh |
Schoeffski, Patrick |
|
utue.personen.roh |
Blay, Jean-Yves |
|
utue.personen.roh |
Kerst, J. Martijn |
|
utue.personen.roh |
Sufliarsky, Josef |
|
utue.personen.roh |
Whelan, Jeremy |
|
utue.personen.roh |
Hohenberger, Peter |
|
utue.personen.roh |
Krarup-Hansen, Anders |
|
utue.personen.roh |
Alcindor, Thierry |
|
utue.personen.roh |
Marreaud, Sandrine |
|
utue.personen.roh |
Litiere, Saskia |
|
utue.personen.roh |
Hermans, Catherine |
|
utue.personen.roh |
Fisher, Cyril |
|
utue.personen.roh |
Hogendoorn, Pancras C. W. |
|
utue.personen.roh |
dei Tos, A. Paolo |
|
utue.personen.roh |
van der Graaf, Winette T. A. |
|
dcterms.isPartOf.ZSTitelID |
Lancet Oncology |
de_DE |
dcterms.isPartOf.ZS-Issue |
4 |
de_DE |
dcterms.isPartOf.ZS-Volume |
15 |
de_DE |